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Mutations in genes affecting endocrine signaling,
stress responses, metabolism, and telomeres can all
increase the life spans of model organisms. These
mutations have revealed evolutionarily conserved
pathways for aging, some of which appear to extend
life span in response to sensory cues, caloric restric-
tion, or stress. Many mutations affecting longevity
pathways delay age-related disease, and the molecu-
lar analysis of these pathways is leading to a mecha-
nistic understanding of how these two processes—
aging and disease susceptibility—are linked.
Introduction
Aging is a fundamental and fascinating process with
great natural diversity. A rat lives three years, whereas
a squirrel lives twenty-five. Some animals age and die
rapidly after mating, while certain fish and turtles do
not seem to age at all. Diversity in the aging process
exists even within a single individual. The neurons of
old, decrepit C. elegans show little signs of age (Hern-
don et al., 2002), and the germ lineage is immortal. In
spite of this diversity, for many years aging was thought
to be a haphazard process driven solely by entropy.
However, we now know that aging, like many other bio-
logical processes, is subject to regulation by pathways
that have been conserved during evolution. Changing
single genes within these pathways can extend life
span dramatically, causing the animal to age normally
but just more slowly. Some of these long-lived mutants
are breathtaking; in human terms, they look like forty-
year-olds when they are actually eighty or even older.
In this review, I describe some of these long-lived mu-
tants and the remarkable insights they provide about
the aging process.
Endocrine Regulation of Aging
Mutations Affecting Insulin/IGF-1 Signaling
Many mutations that extend life span perturb endocrine
signaling. The best understood of these signaling path-
ways is the insulin/IGF-1 pathway, which influences life
span in worms, flies, and mammals (Tatar et al., 2003)
(Figure 1). This pathway was first linked to life span in
C. elegans, where mutations in daf-2, a known regula-
tory gene (Riddle, 1997) encoding an insulin/IGF-1 re-
ceptor ortholog (Kimura et al., 1997), were found to
double the life span of the animal (Kenyon et al., 1993).
The life span extension caused by daf-2 mutations re-
quired the activity of daf-16 (Kenyon et al., 1993), which
encodes a FOXO family transcription factor (Lin et al.,
1997; Ogg et al., 1997). These findings demonstrated*Correspondence: ckenyon@biochem.ucsf.eduthat aging in C. elegans is subject to regulation, and
that it is regulated hormonally.
The DAF-2 receptor activates a conserved PI-3 kinase
signaling pathway (Friedman and Johnson, 1988; Hert-
weck et al., 2004; Morris et al., 1996; Ogg and Ruvkun,
1998; Paradis et al., 1999; Paradis and Ruvkun, 1998;
Wolkow et al., 2002) that affects life span, at least in
part, by regulating the nuclear localization of DAF-16
(Henderson and Johnson, 2001; Lee et al., 2001; Lin et
al., 2001). In addition to DAF-16, HSF-1, the C. elegans
heat-shock transcription factor, is also completely re-
quired for daf-2 mutations to extend life span (Hsu et
al., 2003; Morley and Morimoto, 2004). Like DAF-16
(Henderson and Johnson, 2001; Lee et al., 2001; Lin et
al., 2001), HSF-1 delays aging and extends life span
(Garigan et al., 2002; Hsu et al., 2003; Morley and Mori-
moto, 2004). In daf-2 mutants, HSF-1 promotes longev-
ity by activating specific longevity genes, including
genes that encode small heat-shock proteins (Hsu et
al., 2003).
The longevity of daf-2 mutants also requires the func-
tion of AAK-2, the catalytic subunit of the AMP-acti-
vated protein kinase (Apfeld et al., 2004). In mammals,
AMP kinase regulates energy metabolism and food in-
take via phosphorylation of an array of substrates, in-
cluding metabolic enzymes and transcription factors.
The mechanism by which AAK-2 promotes longevity is
not known, but its overexpression in worms increased
life span w13%, suggesting that AAK-2 has a causal
role.
Insulin/IGF-1 receptor mutations can also increase
the life span of Drosophila, by as much as 80% (Tatar et
al., 2001). In addition, mutations in chico, a downstream
insulin receptor substrate (IRS)-like signaling protein,
increase life span by w40% (Clancy et al., 2001; Tu et
al., 2002a). It seems likely that this life span extension
will be FOXO dependent: first, FOXO is required for the
reduced cell division observed in Drosophila insulin/
IGF-1 pathway mutants (Junger et al., 2003); second,
FOXO overexpression extends the fly’s life span (Gian-
nakou et al., 2004; Hwangbo et al., 2004); and third,
Drosophila genes with conserved FOXO binding sites
have proven to influence life span (Lee et al., 2003).
Unlike worms and flies, which have a single insulin/
IGF-1-like receptor, mice have separate receptors for
insulin and IGF-1. IGF-1 receptor heterozygous knock-
out mice live w30% longer than wild-type, and males
live 16% longer (though the latter value was not statis-
tically significant) (Holzenberger et al., 2003). In addi-
tion, mice that lack the insulin receptor in adipose tis-
sue live w18% longer than wild-type (Bluher et al.,
2003). Thus the ability of insulin/IGF-1 signaling to influ-
ence life span appears to have been distributed to both
receptors during evolution.
Mutations in upstream genes that regulate insulin
and IGF-1 also extend life span, by w50%. For exam-
ple, growth hormone stimulates IGF-1 production, and
growth hormone receptor mutants are long lived
(Coschigano et al., 2003). The Ames and Snell dwarf
mice, which have pituitary defects and consequently
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450Figure 1. Genes, Pathways, and Tissues that Have Been Shown to Influence the Life Spans of More than One Animal Species
Dashed lines, plausible regulatory relationships (see text).low levels of growth hormone and IGF-1, are also long S
Clived (Brown-Borg et al., 1996; Flurkey et al., 2002). GH
and IGF-1 promote growth, but the small size of these w
Smice is unlikely to cause their life span extension be-
cause in worms, flies, and other mouse mutants, it is A
Ipossible to change insulin/IGF-1 receptor activity in
such a way that life span is increased with little or no a
ochange in body size (Clancy et al., 2001; Garigan et al.,
2002; Holzenberger et al., 2003; McCulloch and Gems, m
e2003).
Whether FOXO proteins are responsible for life span a
aextension in mice is not known; however, FOXO pro-
teins function in mouse insulin and IGF-1 pathways that
Aaffect metabolism (Burgering and Kops, 2002). In addi-
tion, FOXO proteins have been implicated in the in- l
rcreased stress resistance of certain long-lived mice,
such as mice lacking the adaptor protein p66shc (Ne- i
tmoto and Finkel, 2002). Stress resistance is a general
feature of insulin/IGF-1 pathway mutants, and in e
tworms, this phenotype has been shown to be FOXO
dependent (Clancy et al., 2001; Holzenberger et al., t
2003; Larsen, 1993; Lin et al., 2001; Lithgow et al., 1995;
Murakami and Johnson, 1996). w
oEven the life span of yeast appears to be regulated
by insulin/IGF-1 signaling components. Mutations in s
1the yeast AKT ortholog SCH9 extend life span (Longo,
2003). SCH9 is likely to be a bona fide AKT ortholog s
rbecause as in flies and mice, it also controls growth;
sch9 mutant yeast are much smaller than wild-type. d
aLikewise, overexpression of the histone deacetylaseir2, which is part of the insulin/IGF-1 pathway in
. elegans, extends the life spans of both yeast and
orms (Tissenbaum and Guarente, 2001).
ignaling Cascades and Tissue Interactions
ffecting Life Span
nsulin/IGF-1 signaling appears to be only one step in
signaling cascade that affects life span. The first hint
f this came from the finding that C. elegans genetic
osaics that lack the DAF-2 insulin/IGF-1 receptor in
ither cell at the two-cell stage are long lived (Apfeld
nd Kenyon, 1998). Thus cells that lack daf-2 must be
ble to send a longevity signal to wild-type cells.
Which tissues produce these downstream signals?
dipose tissue is important since mice lacking the insu-
in receptor in adipose tissue are long lived. A signaling
ole for adipose tissue may be conserved since increas-
ng FOXO activity specifically in adipose tissue extends
he life spans of flies (Giannakou et al., 2004; Hwangbo
t al., 2004), and in worms, increasing FOXO activity in
he intestine, which also serves as the animal’s adipose
issue, extends life span w50% (Libina et al., 2003).
In C. elegans, activity of the insulin-response path-
ay in neurons also influences life span. For example,
ne mosaic animal that lacked daf-2 only in a small
et of neurons was very long lived (Apfeld and Kenyon,
998). The relative importance of neurons is controver-
ial. Wolkow et al. reported that expression of the DAF-2
eceptor only in neurons shortened the life spans of
af-2(−) mutants to daf-2(+) control levels (Wolkow et
l., 2000). However, Libina et al. produced the same
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451type of animals (daf-2 activity only in neurons) using
a daf-2 RNAi feeding strategy (which does not affect
neurons) and found that the animals lived twice as long
as normal (Libina et al., 2003). Moreover, using tissue-
specific gene expression, genetic mosaic analysis and
RNAi, Libina et al. found that daf-16/FOXO activity in
neurons accounted for onlyw5%–20% of the life span
extension seen in daf-2 mutants.
The insulin/IGF-1 pathway controls at least two types
of downstream signals. First, the pathway may feed-
back regulate the production of insulin-like signals. In
C. elegans, increasing DAF-16/FOXO activity in the in-
testine increases DAF-16 activity in other tissues (Lib-
ina et al., 2003). DAF-16 is known to inhibit expression
of the insulin-like gene ins-7, a putative DAF-2 agonist
(Murphy et al., 2003), and reduced insulin levels could
potentially mediate this effect. Likewise, in flies, in-
creasing FOXO activity in adipose tissue inhibits insulin
gene expression in neurons (Hwangbo et al., 2004).
Positive, cell-nonautonomous feedback regulation may
allow the effects of local perturbations in insulin/IGF-1
signaling levels to spread rapidly throughout the ani-
mal. However, it also complicates identification of tis-
sues in which insulin/IGF-1 signaling is particularly im-
portant because experimentally changing the level of
FOXO activity in one tissue can change its activity else-
where.
In C. elegans, DAF-16/FOXO must also produce lon-
gevity signals that do not act through DAF-16/FOXO in
responding cells since restricting DAF-16 activity to the
intestine or neurons increases the life span of the whole
animal (Libina et al., 2003). One candidate for such a
signal is scl-1 (Ookuma et al., 2003), a CRISP family
member that is upregulated by DAF-16/FOXO and is
required for the longevity of daf-2 mutants. Another
possible downstream signaling factor is the tyrosine ki-
nase receptor old-1, which promotes longevity and is
regulated by insulin/IGF-1 signaling (Murakami and
Johnson, 2001). In flies, both juvenile hormone and ec-
dysone production are decreased in long-lived insulin
receptor mutants (Tatar et al., 2003; Tu et al., 2002b),
and juvenile-hormone analogs restore the life spans of
these animals to normal without affecting wild-type lon-
gevity (Tatar et al., 2001). Moreover, ecdysone receptor
mutant heterozygotes live 40%–50% longer than wild-
type (Simon et al., 2003). Thus reducing insulin/IGF-1
signaling may extend life spans in flies, at least in part,
by reducing the level of signaling by juvenile hormone
and ecdysone.
Interestingly, in C. elegans, the heat-shock factor
HSF-1 also acts in a cell-nonautonomous fashion to ex-
tend the life spans of daf-2-pathway mutants (Morley
and Morimoto, 2004). Thus HSF-1 may be doing more
than simply regulating cell-autonomous heat-shock genes.
A Regulatory Module for Longevity
How, ultimately, does insulin/IGF-1 activity influence life
span? In C. elegans, many functionally significant down-
stream genes have now been identified. In one study,
RNAi analysis was used to test the functional signifi-
cance of the fifty genes whose expression was most
strongly changed in daf-2/daf-16 gene expression pro-
files (Murphy et al., 2003). In another, the functional sig-
nificance of a set of genes with conserved FOXO bind-
ing sites was tested with RNAi (Lee et al., 2003). Manyof these genes influenced life span, including antioxi-
dant genes such as superoxide dismutase, metallothio-
nine, catalase, and glutathionine S-transferase (some
of which were known previously to be regulated by
daf-2 [Barsyte et al., 2001; Honda and Honda, 1999;
Vanfleteren and De Vreese, 1995]), metabolic genes in-
cluding apolipoprotein genes, glyoxylate-cycle genes,
and genes involved in amino acid turnover, and chaper-
ones, particularly small heat-shock protein genes, and
antibacterial genes. Overexpression of at least some
genes upregulated in the long-lived mutants, such as
superoxide dismutase (Sun et al., 2002; Sun and Tower,
1999) and small heat-shock protein genes (Walker and
Lithgow, 2003; Wang et al., 2004), can extend life span.
One set of downregulated genes, the apoliporotein
genes, is intriguing since alleles predicted to reduce the
function of genes involved in fat transport in humans
are genetically linked to extreme longevity (Barzilai et
al., 2003; Geesaman et al., 2003). The antibacterial genes
are also interesting since bacterial proliferation contrib-
utes to the death of C. elegans (Garigan et al., 2002;
Gems and Riddle, 2000) and daf-2 mutants are resistant
to pathogens (Garsin et al., 2003).
Autophagy, the turnover of cellular organelles, may
also play an important role in the longevity of daf-2 mu-
tants. Autophagy is increased in daf-2 mutants, and
preventing autophagy shortens their life spans without
affecting those of wild-type (Melendez et al., 2003).
The key concept to emerge from these studies is that
the insulin/IGF-1 system acts as a “longevity module”
in which master regulators like DAF-2 and DAF-16/
FOXO control a wide variety of downstream genes with
diverse functions that act together in a cumulative fash-
ion to influence life span (Figure 2). Many of these
downstream genes are likely to be conserved, with re-
spect to both their function and regulation. For exam-
ple, the longevity of yeast sch9/akt mutants appears to
be due, at least in part, to upregulation of superoxide
dismutase (Fabrizio et al., 2003). Likewise, mammalian
FOXO proteins activate stress-response genes when
insulin or IGF-1 levels are reduced (Kops et al., 2002;
Nemoto and Finkel, 2002; Tran et al., 2002). Many of
these downstream genes may also influence longevity
in humans. In addition, their analysis in different kinds
of animals may help us understand how different spe-
cies can have such different life spans.
Evolution of a Regulatory System for Life Span
How could such a longevity module evolve? It may
have been selected because of its effects on aging if,
for example, species whose members have short life
spans prospered from increased genetic diversity or
decreased competition between parents and offspring.
An alternative explanation is particularly appealing;
namely that the insulin/IGF-1 longevity regulatory mod-
ule arose during evolution not to influence longevity per
se but to allow animals to endure harsh environmental
conditions. Many DAF-2/DAF-16 downstream longevity
genes not only extend life span but also protect the
animal from harsh environmental stress, such as heat,
UV, and oxidative-damaging agents. This would be logi-
cal since metabolic and environmental stresses may in-
flict similar types of damage on cellular components.
The same chaperone, antioxidant, and other proteins
that protect against one type of stress would protect
Cell
452Figure 2. Longevity Regulatory Module
See text for details.against the other. In fact, the stress resistance of verte- n
nbrate cells in culture correlates with the life spans of
the species from which they were isolated (Kapahi et m
eal., 1999).
Consistent with this idea, in C. elegans, the insulin/ C
dIGF-1 pathway not only regulates adult longevity but
also entry of pre-pubescent juveniles into a growth- v
tarrested larval state called dauer (Riddle, 1997). Harsh
environmental conditions trigger dauer formation, in e
epart, by downregulating insulin/IGF-1 signaling. Re-
duced insulin/IGF-1 signaling is likely to endow dauers t
awith their longevity and stress resistance because
many stress-response and other genes whose expres-
bsion changes in long-lived adults also change in dauers
(Jones et al., 2001; McElwee et al., 2004). h
cThe ability of C. elegans to enter the dauer state has
clear selective value because it delays reproduction un- t
ader harsh environmental conditions. Thus the insulin/
IGF-1 life span regulatory module may have evolved ini- u
ctially to allow the animal to survive harsh environmental
conditions before reproducing. But at the same time i
d(because the same genes protect against endogenous
stress that accelerates aging) a means of regulating c
clongevity itself was created.
Are the long-lived insulin/IGF-1 mutants dauers in c
ddisguise? Probably not. Dauers have low metabolism,
a specialized morphology, and they do not reproduce. l
lIn contrast, whereas some daf-2 mutations (class II)
produce dauer-like traits in adults, others (class I muta- o
ations) do not; they have normal metabolism, repro-
duction, behavior, and body morphology (Gems et al., T
s1998; Van Voorhies and Ward, 1999). The same is true
in mice, where long-lived insulin/IGF-1 mutants have pormal rates of oxygen consumption and reproduce
ormally (Holzenberger et al., 2003). Thus the longevity
odule regulated by the insulin/IGF-1 system can be
xpressed independently of many diapause-like traits.
onsistent with this, the insulin/IGF-1 system acts at
ifferent times to control dauer formation (a strictly lar-
al state) and life span. Both DAF-2 and DAF-16 act in
he young juvenile to influence dauer formation; how-
ver, they act exclusively in adults to affect aging (Dillin
t al., 2002a) (The insulin/IGF-1 pathway also appears
o regulate the life spans of flies during adulthood [Gi-
nnakou et al., 2004; Hwangbo et al., 2004]).
In nature, there are short-lived and long-lived insects,
irds, and mammals, so large changes in life span must
ave evolved not once but many times. Moreover, large
hanges in life span can evolve rapidly, for example, in
he case of guppies, over just a few years (Reznick et
l., 2004). The existence of a “life span regulatory mod-
le” may render the process of aging “evolvable” since
hanges in one or a few regulatory genes (or perhaps
ndividual downstream genes) could potentially pro-
uce large changes in life span. During evolution, such
hanges could have allowed animals to enter ecologi-
al niches that favor a longer life span. In fact, recent
hanges in this regulatory system may have produced
ifferent life spans among dogs. Small dogs live much
onger than large dogs, possibly because they have
ower levels of IGF-1 (Eigenmann et al., 1984). In model
rganisms, the effects of insulin/IGF-1 signaling on
ging can be uncoupled from its effects on body size.
hus it will be interesting to learn whether long-lived
pecies in general have lower levels of insulin IGF/1
athway activity than short-lived species.
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Insulin and IGF-1 are clearly beneficial. They are ana-
bolic hormones that promote food storage and growth.
Yet reducing the activities of these hormones also
seems beneficial since it lengthens life span. How can
we explain this apparent paradox? The finding that low
insulin/IGF-1 signaling activates stress resistance genes
provides a possible answer: most likely low signaling
levels shift cells from states of growth, which may not
equip them for long-term survival, to states of mainte-
nance, which do equip them for long-term survival,
thereby delaying aging.
It also seems paradoxical that reduced insulin/IGF-1
signaling extends life span but insulin resistance leads
to type II diabetes. The basis for this is not known, but
there are some interesting issues to consider. First, the
specific perturbation is important: whereas loss of the
insulin receptor in adipose tissue extends mouse life
span, its loss in the liver cause diabetes (Michael et
al., 2000). Presumably this is because adipose tissue
lacking the insulin receptor produces longevity signals
whereas liver lacking the insulin receptor does not.
Second, in worms and flies, reducing the activity levels
of insulin-like peptides, like reducing receptor activity,
can extend life span (Broughton et al., 2005; Li et al.,
2003; Murphy et al., 2003; Wessells et al., 2004). This
finding does not seem paradoxical because in mam-
mals, low-circulating insulin levels are generally associ-
ated with insulin sensitivity and longevity. (In fact, it
would be interesting to learn whether low glycemic-
index (low-carb) diets, which keep insulin levels low,
increase life span.) Thus the real paradox is why, in
mammals, low insulin levels are associated with good
health, but low insulin responsiveness with bad health.
It seems that insulin-resistant cells on the path to type
II diabetes are in a fundamentally different regulatory
state from normal cells exposed to low levels of circu-
lating insulin. Insulin-resistant prediabetic cells signal
the pancreas to overproduce insulin, thereby possibly
creating an insulin gain-of-function situation. In con-
trast, insulin-sensitive cells in animals with low levels
of circulating insulin do not trigger insulin secretion.
Perhaps these cells instead produce downstream lon-
gevity signals.
Aging and Reproduction
A Price for Longevity?
Some evolutionary theories predict that longevity muta-
tions will invariably be associated with reproductive or
other tradeoffs. Obviously this cannot always be true,
or magnificent creatures such as ourselves could never
have evolved such long life spans. The tradeoff theory
has recently suffered a setback: as predicted by evolu-
tionary theory, guppies that have short life spans in na-
ture due to predation grow faster and initiate repro-
duction sooner than guppies without natural predators.
However, when their predators are removed, these
same guppies go on to have more progeny and longer
life spans than guppies without natural predators
(Reznick et al., 2004). Likewise, some long-lived mu-
tants, such as the Drosophila indy (amino acid trans-
porter) mutant, have even more progeny than normal
(Rogina et al., 2000). Thus, clearly, longevity need notbe associated with reduced reproduction. Since they
are not found in nature, it seems likely that long-lived
mutants would be at a disadvantage under some envi-
ronmental conditions. Consistent with this, long-lived
C. elegans age-1/PI-3 kinase mutants compete well
when placed in competition with wild-type under re-
plete conditions, but they are outcompeted when sub-
jected to periods of starvation (Walker et al., 2000).
However, the survival of these same mutants is higher
than wild-type at elevated temperature (Lithgow et al.,
1995). Thus context is important, and it need not always
favor wild-type.
Interestingly, the insulin/IGF-1 pathway regulates
both aging and reproduction, but it regulates the two
processes independently of one another. Treating worms
with daf-2 RNAi from the time of hatching extends life
span and delays reproduction, but treating them as
young adults extends life span to the same extent with
little or no effect on reproduction (Dillin et al., 2002a).
This is interesting because it hints at evolutionary flexi-
bility: single mutations affecting this pathway could po-
tentially affect both aging and reproduction or, alterna-
tively, one but not the other.
Regulation of Life Span by the Reproductive System
Turning the situation on its head, the reproductive sys-
tem can actually regulate aging. When the germline
precursors of C. elegans are removed, life span is ex-
tendedw60% (Hsin and Kenyon, 1999). This is not due
to sterility because removing the entire reproductive
system (germine plus somatic gonad) has no effect on
life span. Instead, the longevity effect is mediated hor-
monally. It is dependent on DAF-16/FOXO and a steroid
signaling pathway involving the nuclear hormone re-
ceptor DAF-12 (Hsin and Kenyon, 1999) and DAF-9, a
cytochrome P450 homolog thought to be involved in
the synthesis of a DAF-12 ligand (Gerisch and Antebi,
2004). Removing the germ cells causes DAF-16 nuclear
localization primarily in the intestine/adipose tissue (Lin
et al., 2001), and its activity there is sufficient to ac-
count for the entire life span extension produced by
removal of the germline (Libina et al., 2003). It is not
clear how germ cells signal to the intestine, but the
germline stem cells seem to be involved. Neither oo-
cytes nor sperm are required for the germline to influ-
ence longevity, but preventing germline stem cell divi-
sion in the adult extends life span (Arantes-Oliveira et
al., 2002).
In wild-type animals, the somatic gonad must be pre-
sent in order for germline ablation to extend life span.
In daf-2 mutants, however, germline ablation further ex-
tends life span whether or not the somatic gonad is
present. Thus in the wild-type, killing the somatic go-
nad may restore to normal the life spans of germline-
ablated animals by activating the insulin/IGF-1 pathway
(Hsin and Kenyon, 1999).
Germline regulation of life span may provide a means
of coordinating the rate of aging with the timing of re-
production. For example, if, during evolution, a muta-
tion occurred that delayed germline development, re-
production would be delayed, but so would the rate of
aging. As a consequence, the animal could still be in
its prime when it reproduced.
An elegant experiment demonstrates that the repro-
ductive system also influences life span in mammals
Cell
454(Cargill et al., 2003). When the ovaries of either young t
aor old mice are transferred into age-matched ovariecto-
mized mice, life span is not affected. However, when d
ayoung ovaries are transplanted into old recipients, life
span is extended 40%–60%. Thus signals from the re- n
nproductive tissues must somehow influence life span.
This transplantation kills the germ cells, so the long- 2
elived mice contain a somatic gonad but no germ cells—
a situation that leads to longevity in worms. Repro- P
sductive signaling could potentially influence fly life span
as well. A mutation that kills oocytes extends life span, w
pas does low-dose X-irradiation, which kills germ cells
(Sgro and Partridge, 1999). i
i
pRegulation of Life Span by Environmental Cues
aStress-Induced Life Span Extension
iThere are many situations in biology in which low levels
Tof stress trigger subsequent beneficial effects. This
Gphenomenon, sometimes called “hormesis,” influences
(aging since transient heat shock can extend the life
espans of flies and worms (Apfeld et al., 2004; Hercus et
dal., 2003; Lithgow et al., 1995). The finding that overex-
Ipression of the heat-shock factor HSF-1 extends life
nspan in C. elegans (Hsu et al., 2003; Morley and Mori-
lmoto, 2004) provides a possible explanation for this in-
fteresting phenomenon; namely, that stress activates
nHSF-1, which, in turn, increases life span by activating
pdownstream life span-extending genes such as small
heat-shock protein genes (Hsu et al., 2003).
nC. elegans DAF-16/FOXO may be involved in hor-
Fmesis as well. Heat shock triggers DAF-16 nuclear lo-
tcalization (Henderson and Johnson, 2001; Lin et al.,
h2001), and DAF-16 is required for the full expression
aof certain heat-shock genes, including the small heat-
wshock protein genes, following heat shock (Hsu et al.,
R2003). Interestingly, heat pulses produce large in-
creases in life span, and large increases in the level o
pof small heat-shock proteins, in long-lived age-1/PI-3
kinase mutations (Walker et al., 2001). This could occur r
because the disinhibition of DAF-16 in these mutants
renders the longevity pathway more sensitive to further d
tactivation by stress. Mutations that increase insulin/
IGF-1 signaling (PTEN mutations) prevent heat from (
Itriggering DAF-16 nuclear localization (Lin et al., 2001).
This raises the possibility that stress increases life c
lspan, at least in part, by downregulating insulin/IGF-1
signaling. c
fActivating the stress-response Jun kinase (JNK)
pathway increases life span in Drosophila by as much
mas 80% (Wang et al., 2003). This pathway would also
be expected to promote stress-induced longevity. In l
oaddition, the AMP kinase subunit AAK-2 is completely
required for transient heat stress—which lowers energy r
tlevels—to increase life span (Apfeld et al., 2004). AAK-2
may sense the effect of stress on energy levels to either (
hsupport, or actually cause, the enhanced longevity of
these animals. b
DTogether these findings raise interesting questions
about the effect of stress on human life span. Could it m
obe that certain types of stress, such as fevers or hot
flashes, might actually have a beneficial effect? t
aRegulation of Life Span by Sensory Perception
Many C. elegans sensory mutants, including animals 1
wwith reduced activity of putative chemosensory recep-ors, are long lived (Alcedo and Kenyon, 2004; Apfeld
nd Kenyon, 1999). This life span extension is largely
af-16 dependent (Alcedo and Kenyon, 2004; Apfeld
nd Kenyon, 1999) and is associated with DAF-16
uclear localization (Lin et al., 2001). Many sensory
eurons produce insulin-like peptides (Pierce et al.,
001), at least some of which have been shown to influ-
nce longevity (Li et al., 2003; Murphy et al., 2003;
ierce et al., 2001). Thus perception may affect life
pan by changing the activity of the insulin/IGF-1 path-
ay. Sensory control of life span is surprisingly com-
lex. Some (but not all) gustatory and olfactory neurons
nfluence life span, and some promote, whereas others
nhibit, longevity (Alcedo and Kenyon, 2004). Sensory
erception may or may not affect life span in higher
nimals, but it is interesting that the smell of food can
ncrease insulin levels in humans (Lindemann, 2001).
he Longevity Response to Dietary Restriction
enes in the Insulin/IGF-1 Pathway. Dietary restriction
DR) extends life span and postpones age-related dis-
ase in many animals, including yeast, worms, flies, ro-
ents, and possibly primates. How does DR do this?
ntuitively, one might expect reduced insulin/IGF-1 sig-
aling to mediate this effect since in mammals, DR
owers insulin levels. This appears to be the case in
lies since the life spans of animals subjected to DR are
ot further increased by mutations in the insulin/IGF-1
athway (Clancy et al., 2002).
In C. elegans, reduced insulin/IGF-1 signaling does
ot mediate the response to DR because DAF-16/
OXO is required for low insulin/IGF-1 signaling to ex-
end life span but not for DR to extend life span (Hout-
oofd et al., 2003; Lakowski and Hekimi, 1998). Instead,
s described above, the insulin/IGF-1 pathway in
orms appears to be regulated by sensory perception.
egulating the insulin/IGF-1 system by the perception
f sensory cues rather than food consumption could
rovide a way for C. elegans to adjust its physiology
apidly in response to a change in the environment.
It is not clear whether the insulin/IGF-1 pathway me-
iates the response to DR in mice. DR nearly doubles
he already long life spans of pituitary mutant mice
Bartke et al., 2001), suggesting that DR and insulin/
GF-1 signaling affect different pathways. However, one
ould argue that DR and the pituitary mutation do affect
ife span in the same way, but that neither the DR proto-
ol employed, nor the pituitary mutation, induces the
ull DR longevity response on its own.
Dietary Restriction, Fat, and Longevity. Long-lived
ice that lack the insulin receptor in adipose tissue are
ean, even when fed a high-fat diet. The same is true
f another long-lived mouse mutant, in which a C/EBP
egulatory mutation has converted white adipose tissue
o the more metabolically active brown adipose tissue
Chiu et al., 2004). The lean phenotypes of such mice
ave suggested the hypothesis that they are long lived
ecause low fat levels trigger the longevity response to
R (Bluher et al., 2003). However, an interesting experi-
ent indicates that this need not be the case: obese
b/ob (leptin-defective) mice subjected to DR are fatter
han well-fed wild-type mice, but they live just as long
s wild-type mice subjected to DR (Harrison et al.,
984). Moreover, long-lived pituitary mutant mice, as
ell as the worm and fly insulin/IGF-1-pathway mu-
Review
455tants, actually accumulate fat. (In worms, fat accumula-
tion can be uncoupled from longevity [Ashrafi et al.,
2003; Kenyon et al., 1993; Kimura et al., 1997; Wolkow
et al., 2000].) Together, all of these findings suggest that
if mutations in the mouse insulin/IGF-1 pathway muta-
tion do trigger the DR longevity response, they trigger
it independently of fat storage.
TOR Signaling. One pathway that might be predicted
to be involved in the response to DR is the nutrient-
sensing TOR (target of rapamycin) pathway. TOR is a
protein kinase that phosphorylates ribosomal S6 kinase
and translation initiation factor 4E binding protein 1, an
inhibitor of the eukaryotic initiation factor 4E, in re-
sponse to nutrients, which in turn promotes growth (In-
oki et al., 2005). Mutations that decrease TOR activity
extend the life spans of both flies (13%–30%) and
worms (w30%) (Jia et al., 2004; Kapahi et al., 2004;
Ramsey et al., 2002). Moreover, the life spans of the
mutant flies cannot be further extended by DR. Thus it
is plausible that the longevity response to DR involves
downregulation of TOR.
SIR2. The molecular response to dietary restriction
has been studied extensively in yeast. In response to
reduced glucose levels, yeast cells undergo a meta-
bolic shift from fermentation to oxidative phosphoryla-
tion. This shift is both necessary and sufficient to
increase life span (Lin et al., 2002). The mechanism by
which this shift extends life span is not clear, but activ-
ity of the histone deacetylase Sir2 is required. Sir2 is an
interesting protein because its activity is NAD depen-
dent. Thus Sir2 may sense, and respond to, the cell’s
metabolic state. Mutant yeast cells that do not gener-
ate life-shortening rDNA circles in response to DR no
longer require Sir2 for DR to extend life span. Thus
there exists a Sir2-independent DR pathway in yeast
(Kaeberlein et al., 2004). The regulation and function of
Sir2 in yeast is discussed in more detail in the review
by Guarente and Picard (2005 [this issue of Cell]).
Sir2#s ability to extend life span has been conserved
during evolution since overexpression of SIR2 ortho-
logs increases the life spans of both worms and flies
(Rogina and Helfand, 2004; Tissenbaum and Guarente,
2001). In worms, SIR-2 seems unlikely to mediate the
longevity response to DR since the life span extension
produced by sir-2 overexpression is daf-16 dependent,
whereas that produced by DR is not. In addition, SIR-2
activity potentiates dauer formation, suggesting that
SIR-2 is part of the insulin/IGF-1 pathway. In flies, the
insulin/IGF-1 pathway appears to mediate the response
to DR, and consistent with this, in flies, Sir2 activity is
required for DR to extend life span. Another deacety-
lase, rpd3, may also function in this pathway in flies.
Reduction of rpd3 activity lengthens life span, and DR
decreases rpd3 expression. This, in turn, increases Sir2
expression (Rogina et al., 2002).
In mammals, the SIR2 ortholog SirT1 has many in-
triguing roles in the regulation of metabolism and hor-
mone signaling (see Guarente and Picard, 2005 [this
issue of Cell]). For example, SirT1 deacetylates FOXO,
which in turn shifts FOXO target selection toward
stress-response genes (Brunet et al., 2004; Daitoku et
al., 2004; Giannakou and Partridge, 2004; Motta et al.,
2004). SirT1 may prove to affect the longevity response
to DR in mammals since SirT1 expression is inducedby DR in mice, and its activity is required for cultured
mammalian cells to undergo additional divisions follow-
ing DR (Cohen et al., 2004).
Interestingly, increased SirT1 activity promotes fat
mobilization by inhibiting activity of the fat regulator
PPAR-γ (Picard et al., 2004). It is possible that SirT1 will
prove to increase mouse life span by decreasing fat
levels since several mouse mutants that have reduced
fat levels are long lived. However, as discussed above,
some long-lived mouse mutants have increased fat
levels. In addition, the antidiabetic thiazolidinediones,
which activate PPAR-γ and increase fat levels, increase
insulin sensitivity and have beneficial health effects
(Savage, 2005). Thus it will be very interesting to learn
how manipulating SirT1 activity influences the life span
of the whole animal.
Metabolic Genes. Reduction of function of Drosoph-
ila indy, which encodes an amino acid transporter,
doubles the mean life span of flies (Rogina et al., 2000).
This mutation does not simply starve the animal be-
cause, unlike DR, it does not decrease and delay repro-
duction. However, indy appears to function in the lon-
gevity response to DR because its long life span cannot
be further lengthened by DR (B. Rogina and S.L. Hel-
fand, personal communication).
clk-1 and Ubiquinone. C. elegans clk-1 mutants, which
are unable to produce ubiquinone, an essential compo-
nent of the electron transport chain, are long lived (Fel-
kai et al., 1999). clk-1 mutants contain a novel ubiqui-
none species called dimethoxy-Q9, which they produce
from a precursor they acquire from bacteria (Jonassen
et al., 2001; Larsen and Clarke, 2002). clk-1 mutants
have normal metabolism and ATP levels, so dimethoxy-
Q9 presumably functions in electron transport. How-
ever, it is also distributed to the plasma membrane and
other locations; so it is not clear whether or not the
animal’s long life is caused by changes in mitochondrial
activity. The longevity of clk-1 mutants is not further
enhanced by “eat” mutations, which cause DR and life
span extension, suggesting that clk-1 functions in the
DR pathway (Lakowski and Hekimi, 1998). The longev-
ity phenotype of clk-1 mutants can be rescued with ma-
ternal clk(+) product, so the gene may function in the
adult to influence life span (Jonassen et al., 2001). Con-
sistent with this, initiation of DR during adulthood ex-
tends life span in worms and other animals.
A Puzzle. On the whole, worm and fly mutants be-
have differently when subjected to DR. So far, a Dro-
sophila longevity mutation that can further extend the
life spans of animals subjected to DR has yet to be
reported. In contrast, all but one of the worm mutations
examined further extend the life spans of animals sub-
jected to DR. Perhaps worms would behave more like
flies if they were subjected to DR in a different way. Or
perhaps genes that mediate the longevity response to
DR in flies instead mediate a longevity response to sen-
sory cues in worms, and the worm DR response is reg-
ulated in a different way.
Mitochondrial Mutations that Increase Life Span
Reactive oxygen species (ROS) damage cellular macro-
molecules and are thought to accelerate aging. Consis-
tent with this, growth in low oxygen lengthens the life
Cell
456span of C. elegans, and growth in high oxygen shortens g
rlife span (Honda et al., 1993). ROS are generated during
respiration, and some respiratory-chain mutations shorten a
mlife span and accelerate age-related phenotypes, such
as lipofuscin accumulation. These mutations, typified r
by the C. elegans mev-1(kn1) (succinate dehydroge-
nase cytochrome b) point mutation, appear to acceler- o
aate aging by increasing ROS levels (Ishii et al., 1998).
A number of mutations affecting respiration increase f
rlife span, and at least some may do this by decreasing
ROS levels, though this has not been examined directly. a
fTwo Respiratory-Chain Longevity
Phenotypes in Yeast t
oAs described above, a shift from fermentation to oxida-
tive respiration in yeast extends life span (Lin et al., c
t2002). Conversely, yeast mutations that inhibit respira-
tion have also been reported to increase life span. This b
(life span extension may require genes that mediate the
“retrograde response,” a process by which inhibition of s
grespiration stimulates nuclear gene expression (Kirch-
man et al., 1999). a
wTwo Respiratory-Chain Longevity
Phenotypes in Worms r
aAs in yeast, in C. elegans, life span is increased by RNAi
inhibition of respiratory-chain components (Dillin et al., i
l2002b; Lee et al., 2002). Surprisingly, respiratory-chain
RNAi only increases life span if administered during de- w
ovelopment (Dillin et al., 2002b). If inhibiting respiration
extended life span by reducing ROS levels, then one
would expect it to influence life span in an ongoing way, A
throughout life. Instead, the animal’s life span may be S
extended because it undergoes a regulated response w
to reduced respiration early in life that subsequently in- a
creases its life span. l
Curiously, qm50, a point mutation in the C. elegans p
gene isp-1, which encodes a component of respiratory- 1
chain complex III, extends life span but causes a dif- (
ferent phenotype (Feng et al., 2001). First, this isp-1 e
mutant has a normal body size. In addition, respiratory- t
chain RNAi further extends the life spans of daf-2 d
mutants, but this isp-1 mutation does not. Like daf-2 2
mutants, this isp-1 mutant is paraquat resistant and f
expresses increased levels of superoxide dismutase; i
however, its effect on life span is daf-16 independent. T
Together these findings suggest that this isp-1 mutation P
and daf-2 mutations may ultimately influence the same I
downstream process. g
In summary, these mitochondrial mutations, and the a
clk-1 ubiquinone mutations described above, produce (
a fascinating array of unexpected effects on life span. t
Clearly we have much more to learn about how mito- t
chondria influence life span. a
a
tTelomeres and Life Span
In many human tissues, telomeres progressively shorten v
twith age. Forced expression of the telomere-extending
enzyme telomerase can prevent human cells in culture m
tfrom undergoing senescence (Bodnar et al., 1998). This
finding supports the hypothesis that organismal aging, g
Ctoo, is caused by telomere shortening. Consistent with
this, overexpressing a protein that lengthens telomeres T
mextends the life span of C. elegans (Joeng et al., 2004).
This is intriguing because the somatic cells of C. ele- aans are postmitotic, so they are not susceptible to
eplicative telomere shortening. The long-lived animals
re stress resistant, suggesting unusually long telo-
eres may lengthen life span by inducing stress-
esponse proteins.
Telomere shortening is unlikely to be a general cause
f aging since mice age and die with long telomeres
nd loss of telomerase in mice has no effect on aging
or several generations (Blasco et al., 1997). However,
ecent findings strengthen the case that telomeres may
ffect aging in humans. First, telomere length has been
ound to correlate with longevity and disease resis-
ance in humans (Cawthon et al., 2003). In addition, loss
f the Werner’s gene, which encodes a DNA helicase,
auses progeria (accelerated aging) in humans. Loss of
he same gene in normal mice does not cause progeria,
ut loss of the gene in mice that lack telomerase does
Chang et al., 2004). This finding implies that telomere
hortening makes humans susceptible to Werner’s pro-
eria syndrome, which in turn suggests that telomeres
re involved in normal human aging. Interestingly, both
ith and without the Werner’s mutation, aging telome-
ase-knockout mice exhibit phenotypes that are char-
cteristic of old humans rather than old mice. Perhaps
ncreasing telomere length will prove to increase human
ife span after all. And when we do get old, perhaps
e will acquire signs of aging that are more like those
f mice.
ge-Related Disease
usceptibility to a wide variety of diseases increases
ith age. We are 100 times more likely to have a tumor
t age 65 than at age 35. What, at the molecular level,
inks aging to age-related disease? It is not simply the
assage of time. Mice exhibit high rates of cancer at
.5 years (mean life span, 2 years), dogs at 10 years
life spanw12 years), and humans after decades. Inter-
stingly, long-lived insulin/IGF-1 mutants are resistant
o many age-related diseases, including Huntington’s
isease in a C. elegans disease model (Morley et al.,
002), sarcopenia in worms (Herndon et al., 2002), heart
ailure in Drosophila (Wessells et al., 2004), and cancer
n rodents (Bielschowsky, 1961; Ramsey et al., 2002).
hus this pathway couples aging to age-related disease.
rotein Aggregation
n at least one case, Huntington’s disease in the C. ele-
ans model, a direct molecular link between normal
ging and disease susceptibility has been identified
Hsu et al., 2003). Life span-extending insulin/IGF-1 mu-
ations increase expression of small heat shock pro-
eins, and these proteins not only increase life span but
lso delay the time of onset of Huntingtin-like protein
ggregates. Small heat-shock proteins are chaperones
hat bind to damaged or misfolded proteins and pre-
ent their aggregation (Haslbeck, 2002). By doing this,
hey could assist in the maintenance or turnover of nor-
al cellular components, thereby forestalling aging and
hey could also delay disease-related protein aggre-
ation.
ancer
he incidence of cancer rises with age partly because
ore than one genetic alteration (“hit”) is required. In
ddition, something correlated with biological (rather
Review
457than chronological) age must affect the likelihood of
these hits. Mutations that upregulate insulin/IGF-1 sig-
naling, such as PTEN tumor-suppressor mutations,
increase the incidence of cancer. Insulin/IGF-1 signal-
ing potentiates cancer, at least in part, by downregulat-
ing FOXO activity, which would otherwise activate
genes that inhibit cell growth, such as p21Cip1 (Seoane
et al., 2004), or trigger apoptosis, such as fas ligand
and Bim (Brunet et al., 1999; Dijkers et al., 2000). In
addition, PTEN mutations activate the growth-promot-
ing TOR pathway, and this appears to promote certain
types of cancer as well (Inoki et al., 2005). The genetic
analysis of aging predicts that if insulin/IGF-1 signaling
were more effective in one species than another, that
species would have a shorter life span and a higher
cancer susceptibility “set point.” Whether the same
FOXO target genes that affect cancer also affect aging
is not clear. It is possible that FOXO activates the ex-
pression of one set of genes that inhibits cancer and
another set (stress resistance genes perhaps) that influ-
ences aging.
Some mutations that increase cancer resistance, for
example, certain gain-of-function p53 mutations (Tyner
et al., 2002), decrease mouse life span and thereby
break the correlation between longevity and cancer re-
sistance. Either such mutations did not play an impor-
tant role in the coevolution of longevity and cancer re-
sistance, or their deleterious effects were offset by
mutations in other genes.
Neuronal Degeneration
Increased activity of the mammalian SIR2 homolog
SirT1 can promote axon regrowth after injury (Araki et
al., 2004). The “Wallerian degeneration slow” (wlds) mu-
tation delays Wallerian degeneration in response to
axon injury because it causes overexpression of an
NAD biosynthetic enzyme, which in turn activates
SirT1. How SirT1 prevents degeneration is not known,
but if the protective mechanism is a general one, then
SirT1 may also protect cells from neurodegenerative
disease, again potentially linking age-related disease to
the aging process itself.
Prospects
Changes in many more genes, too numerous to de-
scribe here, also extend life span. Together all of these
mutations make it immensely clear that the rate of
aging is plastic and amenable to change. Moreover,
truly astounding life span extensions are possible. For
example, in C. elegans, removing the reproductive sys-
tem and decreasing daf-2 activity in the same animals
extends life span by 6-fold. These animals have a nor-
mal appearance and remain vigorous for many months
(Arantes-Oliveira et al., 2003). In human terms, they
would be the equivalent of healthy, active 500-year-
olds. A life span extension of this magnitude was once
unthinkable, but still it pales in comparison to the thou-
sand-fold life span extension that must have taken
place as we humans evolved from animals living only a
few weeks.
It may not be possible to slow the rate of aging in
humans. But why has it taken so long for us to seriously
try? Perhaps it is because there are no extremely long-
lived, talented primates for us to emulate. It is unlikelythat we would have invented airplanes without seeing
birds fly. Now genetics has given us long-lived model
organisms for inspiration instead.
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